You are viewing: France Nucleic Acid Isolation and Purification Market analysis

The France Nucleic Acid Isolation and Purification Market was valued at $109.85 Million in 2026 and projected to reach to $167.53 Million by 2031, representing a compound annual growth rate of 8.8%. France's nucleic acid isolation and purification market is poised for sustained growth through 2031, driven by expanding molecular diagnostics capabilities and increased genomic research initiatives.

France Nucleic Acid Isolation and Purification Market Trends and Insights

  • This expansion reflects France's strengthening position in molecular diagnostics and genomic research, driven by increased investment in life sciences infrastructure and rising demand for advanced laboratory technologies.
  • France's healthcare sector continues to prioritize precision medicine initiatives, which directly fuel demand for high-quality nucleic acid extraction solutions across clinical and research settings. The French market benefits from a well-established pharmaceutical and biotechnology ecosystem, with major research institutions and diagnostic laboratories requiring sophisticated purification systems.
  • France's commitment to genomic research and personalized medicine has accelerated adoption of automated and manual nucleic acid isolation platforms.
  • Between 2026 and 2031, France is expected to see sustained growth as healthcare providers and research organizations invest in next-generation sequencing capabilities and molecular testing infrastructure. France's regulatory environment and emphasis on quality standards further support market expansion, as laboratories seek certified and reliable isolation and purification solutions to meet stringent compliance requirements..

Key Market Statistics

  • CAGR (2026-2031) : 8.8% CAGR
  • Market Size, 2026 : ~USD 109.85
  • Forecast, 2031 : ~USD 167.53
  • Country : France

France Nucleic Acid Isolation and Purification Market Overview

Market Valuation Growth :

France's nucleic acid isolation and purification market is valued at USD 109.85 million in 2026, with a projected expansion to USD 167.53 million by 2031, representing a robust 8.8% CAGR.

Molecular Diagnostics Expansion :

France is strengthening its position in molecular diagnostics through increased adoption of nucleic acid isolation technologies in clinical laboratories and research institutions across the country.

Life Sciences Infrastructure Investment :

Significant government and private sector investments in French life sciences infrastructure are driving demand for advanced nucleic acid purification systems and reagents.

Genomic Research Acceleration :

Rising demand for genomic research capabilities in France is fueling adoption of high-quality nucleic acid isolation and purification technologies among academic and commercial research centers.

France Nucleic Acid Isolation and Purification Market Dynamics

  • The country's commitment to advancing life sciences infrastructure and strengthening its position in precision medicine is creating favorable conditions for market expansion.
  • Healthcare institutions and research organizations across France are increasingly investing in state-of-the-art nucleic acid purification technologies to enhance diagnostic accuracy and research productivity.
  • This growth trajectory reflects broader European trends toward personalized medicine and molecular-level disease understanding, positioning France as a key market for innovative isolation and purification solutions..

Related Ecosystem

Advanced Genetic Sequencing

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Reagents
  • Assay Kits
  • Bioinformatics
  • Flow Cytometry
Top Companies
  • Thermo Fisher Scientific Inc.
  • Illumina, Inc.
  • Qiagen N.V.
  • Agilent Technologies, Inc.
  • Danaher Corporation

    Biotechnology

    Top Technologies
    • Reagents
    • Polymerase Chain Reaction (PCR)
    • Stem Cells
    • Assay Kits
    • Flow Cytometers
    Top Companies
    • Thermo Fisher Scientific Inc.
    • Merck KGaA
    • Danaher Corporation
    • Agilent Technologies, Inc.
    • Bio-Rad Laboratories, Inc.

      Key Takeaways

      • France's nucleic acid isolation and purification market is valued at USD 109.85 million in 2026 and is forecast to reach USD 167.53 million by 2031.
      • France is experiencing an 8.8% compound annual growth rate, reflecting strong demand from molecular diagnostics and genomic research sectors.
      • France's investment in precision medicine and next-generation sequencing infrastructure is driving adoption of advanced isolation and purification technologies.
      • France's stringent regulatory standards and quality requirements position the market for sustained growth among certified laboratory solution providers.

      France Nucleic Acid Isolation and Purification Market Report Scope

      Report Metric Details
      Base Year 2026
      Fastest Growing Segment CELL-FREE SAMPLES (Sample Type)
      Forecast Period 2026–2031
      Growth Rate CAGR of 8.7% from 2026 to 2031
      Largest Segment CELLULAR SAMPLES (Sample Type)
      Market Size Base Year 6.37 (2026)
      Revenue Forecast 9.66 (2031)
      Segments Covered Product, Type, Method, Sample Type

      France Nucleic Acid Isolation and Purification Market Report Segmentation

      4 segment dimensions are covered across the global market.

      By Product

      • Instruments
      • Kits
      • Reagents

      By Type

      • Automatic Instruments
      • Bacterial Cells
      • Cfdna/Ctdna
      • Circulating Nucleic Acid Isolation And Purification
      • Cultured Cells
      • Ffpe
      • Fresh/Frozen Tissues
      • Genomic Dna Isolation And Purification
      • Manual Instruments
      • Messenger Rna Isolation And Purification
      • Microrna Isolation And Purification
      • Other Cell-Free Samples
      • Other Cellular Samples
      • Other Nucleic Acid Isolation And Purification Types
      • Other Preserved Tissue Samples
      • Plasmid Dna Isolation And Purification
      • Total Rna Isolation And Purification
      • Wbcs

      By Method

      • Column-Based Isolation And Purification
      • Magnetic Bead-Based Isolation And Purification
      • Other Isolation And Purification Methods
      • Reagent-Based Isolation And Purification

      By Sample Type

      • Cell-Free Samples
      • Cellular Samples
      • Other Samples
      • Preserved Tissue Samples

      Target Audience

      • In Vitro Diagnostics (IVD) Manufacturers : IVD companies need France-specific market data to develop localized product strategies, understand demand patterns, and identify opportunities for nucleic acid isolation kit distribution across French diagnostic laboratories.
      • Life Sciences Research Institutions : French universities, research centers, and genomic institutes require market insights to benchmark their nucleic acid purification capabilities, identify technology upgrades, and justify budget allocations for advanced equipment.
      • Clinical Laboratory Operators : Hospital laboratories and independent diagnostic centers in France need market intelligence to evaluate supplier options, assess technology trends, and optimize their nucleic acid isolation workflows for improved efficiency.
      • Healthcare Investment Firms : Private equity and venture capital investors targeting the French life sciences sector need detailed market data to evaluate investment opportunities in nucleic acid isolation technology companies and diagnostic service providers.
      • Pharmaceutical and Biotech Companies : French and international pharma companies require market insights to support drug development, clinical trial operations, and companion diagnostic development that depend on reliable nucleic acid isolation and purification technologies.

      Key Companies in the France Nucleic Acid Isolation and Purification Market

      CompanyHQOwnershipStrongest segments
      SIGMA-ALDRICH CORPORATIONUnited StatesPrivate CompanyAnalytical chemistry, labware, and materials science,Cell culture media, critical raw materials, and industrial microbiology,Molecular biology, functional genomics, and protein biology,
      BECKMAN COULTERUnited StatesPrivate CompanyClinical diagnostics (chemistry, immunoassay, hematology, urinalysis, hemostasis),Flow cytometry and cellular analysis,Life science research tools (centrifugation, genomics, liquid handling, spectrophotometry),
      FLUOR CORPORATIONUnited StatesPublic CompanyEnergy Solutions (traditional and transition EPC),Urban Solutions (AT&M, life sciences, mining, infrastructure),Mission Solutions (government, nuclear remediation, security),
      SANOFIFrancePublic CompanyVaccines (pediatric, RSV, hexavalent, travel),Immunology & Inflammation,Rare Diseases & Neurology,
      GE HEALTHCAREUnited StatesPublic CompanyImaging,Advanced Visualization Solutions (including Ultrasound and Image-Guided Therapies),Patient Care Solutions,
      THERMO FISHER SCIENTIFIC INC.United StatesPublic CompanyLife Sciences Solutions,Analytical Instruments,Specialty Diagnostics,
      QIAGEN N.V.NetherlandsPublic CompanySample technology consumables and instruments,Immune response and infectious disease diagnostics,Oncology and sexual/reproductive health assays,
      MERCK KGAAGermanyPublic CompanyLife Science,Healthcare,Electronics,
      DANAHER CORPORATIONUnited StatesPublic CompanyBiotechnology (bioprocessing and related solutions),Life Sciences (research tools and genomic solutions),Diagnostics (clinical instruments, consumables, software),
      AGILENT TECHNOLOGIES, INC.United StatesPublic CompanyLife Sciences and Diagnostics Markets,Agilent CrossLab,Applied Markets,
      BIO-RAD LABORATORIES, INC.United StatesPublic CompanyClinical Diagnostics,Life Science Research & Bioprocess,
      ILLUMINA, INC.United StatesPublic CompanySequencing instruments,Sequencing consumables (reagents, flow cells, library prep),Array-based products,
      TAKARA BIO INC.JapanPrivate CompanyGenetic and cellular research reagents,PCR instruments and cellular analysis devices,In vitro diagnostics (including COVID-19),
      REVVITY INC.United StatesPublic CompanyDiagnostics (prenatal, neonatal, infectious disease, immunodiagnostics),Life science reagents and assay platforms,Instruments, imaging, and detection systems,
      BIONEER CORPORATIONSouth KoreaPublic CompanyPCR / RT-PCR and real-time PCR reagents and instruments,Molecular diagnostics kits and MDx extraction systems,Research reagents, RNAi, chemicals, buffers, and consumables,

      SIGMA-ALDRICH CORPORATION

      Sigma-Aldrich Corporation is a United States-based private company founded in 1951 that employs 9,800 people. The company specializes in providing research chemicals, biochemicals, and laboratory supplies to the scientific community.

      BECKMAN COULTER

      Beckman Coulter is a United States-based private company founded in 1935 with 11,900 employees. The company manufactures and distributes laboratory instruments and diagnostic equipment.

      FLUOR CORPORATION

      Fluor Corporation is a United States-based public company founded in 1912 with 22,995 employees. The company provides engineering, procurement, and construction services across multiple industries.

      SANOFI

      Sanofi is a France-based public company founded in 1994 with 74,846 employees. The company is a global pharmaceutical organization engaged in the research, development, and commercialization of medicines.

      GE HEALTHCARE

      GE Healthcare is a United States-based public company founded in 2022 with 54,000 employees. The company provides medical imaging, diagnostics, and healthcare IT solutions.

      THERMO FISHER SCIENTIFIC INC.

      Thermo Fisher Scientific Inc. is a United States-based public company founded in 1956 with 125,000 employees. The company is a global leader in serving science, providing laboratory equipment, reagents, and analytical instruments.

      QIAGEN N.V.

      QIAGEN N.V. is a Netherlands-based public company founded in 1984 with 5,500 employees. The company develops and manufactures molecular diagnostics and life sciences research products.

      MERCK KGAA

      Merck KGaA is a Germany-based public company founded in 1668 with 59,077 employees. The company operates in pharmaceuticals, life sciences, and performance materials sectors.

      DANAHER CORPORATION

      Danaher Corporation is a United States-based public company founded in 1969 with 59,000 employees. The company operates a diversified portfolio of businesses in life sciences, diagnostics, and environmental solutions.

      AGILENT TECHNOLOGIES, INC.

      Agilent Technologies, Inc. is a United States-based public company founded in 1999 with 18,000 employees. The company provides laboratory instruments, software, and services for life sciences and diagnostics.

      BIO-RAD LABORATORIES, INC.

      Bio-Rad Laboratories, Inc. is a United States-based public company founded in 1952 with 7,450 employees. The company manufactures and distributes life science research products and clinical diagnostics equipment.

      ILLUMINA, INC.

      Illumina, Inc. is a United States-based public company founded in 1998 with 8,625 employees. The company develops and manufactures DNA sequencing and genetic analysis systems.

      TAKARA BIO INC.

      Takara Bio Inc. is a Japan-based private company founded in 2002 with 1,779 employees. The company specializes in biotechnology products and services for research and diagnostics.

      REVVITY INC.

      Revvity Inc. is a United States-based public company founded in 1937 with 11,000 employees. The company provides analytical instruments, software, and services for life sciences and diagnostics.

      BIONEER CORPORATION

      Bioneer Corporation is a South Korea-based public company founded in 1992 with 392 employees. The company develops and manufactures molecular biology reagents and diagnostic products.

      Reasons to Buy this Report

      • Country-Specific Market Sizing : Obtain precise market valuation data for France with verified figures for 2026 (USD 109.85M) and 2031 (USD 167.53M), enabling accurate financial forecasting and investment planning specific to the French market.
      • Competitive Landscape Intelligence : Understand the competitive dynamics within France's nucleic acid isolation market, including key players, market share distribution, and strategic positioning of suppliers targeting French healthcare and research institutions.
      • Growth Driver Analysis : Identify the specific factors driving France's 8.8% CAGR, including molecular diagnostics expansion, genomic research initiatives, and life sciences infrastructure investments unique to the French market.
      • Regulatory and Market Entry Insights : Access France-specific regulatory requirements, compliance standards, and market entry strategies essential for successfully launching or expanding nucleic acid isolation and purification products in the French market.
      • Strategic Partnership Opportunities : Identify potential collaboration and partnership opportunities with French research institutions, diagnostic laboratories, and healthcare providers to accelerate market penetration and product adoption.

      Frequently asked questions

      What is the current market size of nucleic acid isolation and purification in France?

      France's nucleic acid isolation and purification market was valued at USD 109.85 million in 2026, according to verified market data.

      What is the projected market size for nucleic acid isolation and purification in France by 2031?

      France's market is projected to reach USD 167.53 million by 2031, representing significant growth over the forecast period.

      What is the growth rate of the nucleic acid isolation market in France?

      France's nucleic acid isolation and purification market is growing at a compound annual growth rate (CAGR) of 8.8% from 2026 to 2031.

      What factors are driving growth in France's nucleic acid isolation market?

      Growth in France is driven by increased investment in genomic research, expansion of precision medicine initiatives, rising demand for molecular diagnostics, and adoption of next-generation sequencing technologies.

      How does France's market compare to the global nucleic acid isolation market?

      France's 8.8% CAGR is slightly higher than the global average of 8.7%, indicating that France is outpacing global market growth trends in this sector.

      RESEARCH METHODOLOGY

      This research study extensively used secondary sources, directories, and databases to identify and collect valuable information to analyze the global nucleic acid isolation and purification market. In-depth interviews were conducted with primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of leading market players, and industry consultants, to obtain and verify critical qualitative and quantitative information and to assess the market's growth prospects. The global market size estimated through secondary research was then triangulated with primary research inputs to arrive at the final market size.

      Secondary Research

      Secondary research was used mainly to identify and collect information for the extensive, technical, market-oriented, and commercial study of the global nucleic acid isolation and purification market. The secondary sources used for this study include WHO Disease Statistics (Oncology, Genetic Disorders), CMS Clinical Laboratory Improvement Amendments (CLIA) Laboratory Lists, Association of Public Health Laboratories (APHL) List, Regional Forensic Laboratories list, State Office of Chief Medical Examiner (OCME) List, Biocluster List of Members (Massbio, NC Bio, CLSA), Organization for Economic Co-operation and Development (OECD) R&D Expenditure, National Animal Health Laboratory Network (NAHLN) laboratories List, Genome Canada Membership List, Genome Canada Laboratories Network, Canada Statistics Business Enterprise R&D Statistics, EudraGMP Sites, Biodeutschland Member List, European Federation of Pharmaceutical Industries and Associations (EFPIA) R&D Spending, European Union Drugs Agency (EUDA) Network of forensic and toxicological laboratories list, EudraGMP Sites, BioIndustry Association Member List, NHS Genomics Laboratories Hub, UK Health Security Agency's Laboratories List, FranceBiotech List, China Pharmaceutical Industry Association (CPIA) Member List, China Chinese Center for Disease Control and Prevention (CDC) National Institute for Viral Disease Control and Prevention (IVDC) Laboratories, Japan Pharmaceutical Manufacturers Association (JPMA) & Japanese Bankers Association (JBA) Statistics, NIID (National Institute of Infectious Diseases) reference labs, Indian Pharmaceutical Association (IPA) and Organisation of Pharmaceutical Producers of India (OPPI) Membership List, Brazilian Association of Research-Based Pharmaceutical Industries (Interfarma), Fiocruz Genomic Network Institutes, KAUST Research and Technology Park Companies, Saudi Public Health Authority (Weqaya) National Reference Laboratory System, African Biomedical Engineering Consortium List, Africa CDC Pathogen Genomics Initiative (Africa PGI) Sequencing Laboratories; corporate filings such as annual reports, SEC filings, investor presentations, and financial statements; press releases; and trade, business, professional associations. These sources were also used to obtain key information on major players, market classification, and segmentation aligned with industry trends, regional/country-level markets, market developments, and technology perspectives.

      Primary Research

      Following an initial assessment of the global nucleic acid isolation and purification market landscape through secondary research, comprehensive primary research was undertaken. This involved conducting in-depth interviews with market experts from the demand side, including stakeholders from pharmaceutical and biotechnology firms, CROs, CMOs, and academic and research institutions. Additionally, interviews were conducted with key supply-side participants, including C-suite and senior executives, product managers, and marketing and sales leaders from prominent manufacturers, distributors, and channel partners. The research covered six major geographical regions: North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. Approximately 70% of the primary interviews were conducted with supply-side participants, while 30% were conducted with demand-side experts. Data collection methods included structured questionnaires, email correspondence, online surveys, personal interviews, and telephonic discussions to comprehensively understand market dynamics.

      Nucleic Acid Isolation and Purification market 
 Size, and Share

      To know about the assumptions considered for the study, download the pdf brochure

      Market Size Estimation

      Both bottom-up and top-down approaches were used to estimate and validate the total size of the global nucleic acid isolation and purification market. These methods were also widely used to estimate the sizes of various subsegments in the market. The research methodology used to estimate the market size includes the following:

      • A list of the major global players operating in the nucleic acid isolation and purification market was generated.
      • The revenues generated from their nucleic acid isolation and purification product portfolios have been determined through annual reports and secondary sources (including paid databases).
      • The products were mapped according to the segments of the market. Percentage shares and splits were determined based on each segment's revenue contribution. This was verified using secondary sources and by industry experts.
      • All assumptions, approaches, and individual shares/revenue estimates were validated through expert interviews.

      Nucleic Acid Isolation and Purification market Top Down and Bottom Up Approach

      Data Triangulation

      After arriving at the market size from the estimation process explained above, the total market was divided into several segments and subsegments. To complete the overall market engineering process and obtain exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, as applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

      Market Definition

      Nucleic acid isolation and purification is a set of molecular biology techniques used for the extraction of DNA and RNA for use in downstream applications, such as sequencing, cloning, and polymerase chain reaction. These downstream applications are important parts of life science research, molecular diagnostics, forensics, and genetic engineering. The report defines the Nucleic acid isolation and purification market as the supplier revenue market for kits, reagents, and instruments used for method, application, type of nucleic acid, and type of samples as described below in the inclusions and exclusions.

      Key Stakeholders

      • OEMs, contract manufacturers, and distributors of nucleic acid isolation and purification kits, reagents, and instruments
      • Start-ups, platform technology & service providers
      • Diagnostic centers, government hospitals, and private clinics
      • Pharmaceutical & biotechnology companies
      • Contract research organizations and other service providers
      • Government institutions & associations funding pharmaceutical & biotechnology R&D
      • Venture capitalists and investors
      • Research associations related to genomics
      • Forensic laboratories
      • Veterinary hospitals/clinics
      • Food testing laboratories

      Report Objectives

      • To define, describe, and forecast the global nucleic acid isolation and purification market based on product, method, type, sample type, application, and end user
      • To provide detailed information regarding the major factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
      • To strategically analyze micromarkets concerning individual growth trends, prospects, and contributions to the nucleic acid isolation and purification market
      • To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
      • To forecast the size of the market segments concerning six main regions: North America, Europe, Asia Pacific, Latin America, Middle East, and Africa
      • To profile the key players in the global nucleic acid isolation and purification market and comprehensively analyze their product portfolios, market positions, and core competencies
      • To analyze competitive developments such as product approvals and launches, expansions, agreements, and collaborations in the nucleic acid isolation and purification market
      • To benchmark players within the nucleic acid isolation and purification market using the company evaluation matrix framework, which analyzes market players based on various parameters within the broad categories of business and service strategy

      Available customizations:

      With the given market data, MarketsandMarkets offers customizations to meet your company's needs. The following customization options are available for this report:

      Portfolio Assessment

      • Product Matrix, which gives a detailed comparison of the product portfolios of the top three companies.

      Company Information

      • Detailed analysis and profiling of additional market players (up to three).

      Geographical Analysis

      • A further breakdown of the Rest of Asia Pacific nucleic acid isolation and purification market into countries
      • A further breakdown of the Rest of Europe nucleic acid isolation and purification market into countries
      • A further breakdown of the Rest of Latin America nucleic acid isolation and purification market into countries

       

      Get the Full Nucleic Acid Isolation and Purification Market Report

      Full forecast, segment splits, and company analysis for all Nucleic Acid Isolation and Purification Market.

      Need a Tailored Report?

      Customize this report to your needs

      Get 10% FREE Customization

      Customize This Report
      Fact checked
      DMCA.com Protection Status